For example, several associations with BRAF(A) did not validate in the Score dataset; this is not surprising since the majority of BRAF(A) mutations in the Avana dataset are in the 54 skin cancer cell lines, while the Score dataset contains only 4 skin cancer cell lines (Table S5). The gene discussed is BRAF; the disease is skin neoplasm.